Synthetic SARS-CoV-2 Spike-Based DNA Vaccine Elicits Robust and Long-Lasting Th1 Humoral and Cellular Immunity in Mice

por Alamri, Sawsan S., Alluhaybi, Khalid A., Alhabbab, Rowa Y., Basabrain, Mohammad, Algaissi, Abdullah, Almahboub, Sarah, Alfaleh, Mohamed A., Abujamel, Turki S., Abdulaal, Wesam H., ElAssouli, M-Zaki, Alharbi, Rahaf H., Hassanain, Mazen, Hashem, Anwar M.
Publicado 2021

Cellular and Humoral Immunogenicity of a Candidate DNA Vaccine Expressing SARS-CoV-2 Spike Subunit 1

por Alluhaybi, Khalid A., Alharbi, Rahaf H., Alhabbab, Rowa Y., Aljehani, Najwa D., Alamri, Sawsan S., Basabrain, Mohammad, Alharbi, Rehaf, Abdulaal, Wesam H., Alfaleh, Mohamed A., Tamming, Levi, Zhang, Wanyue, Hassanain, Mazen, Algaissi, Abdullah, Abuzenadah, Adel M., Li, Xuguang, Hashem, Anwar M.
Publicado 2021

SARS-CoV-2 S1 and N-based serological assays reveal rapid seroconversion and induction of specific antibody response in COVID-19 patients

por Algaissi, Abdullah, Alfaleh, Mohamed A., Hala, Sharif, Abujamel, Turki S., Alamri, Sawsan S., Almahboub, Sarah A., Alluhaybi, Khalid A., Hobani, Haya I., Alsulaiman, Reem M., AlHarbi, Rahaf H., ElAssouli, M.-Z.aki, Alhabbab, Rowa Y., AlSaieedi, Ahdab A., Abdulaal, Wesam H., Al-Somali, Afrah A., Alofi, Fadwa S., Khogeer, Asim A., Alkayyal, Almohanad A., Mahmoud, Ahmad Bakur, Almontashiri, Naif A. M., Pain, Arnab, Hashem, Anwar M.
Publicado 2020

Early Humoral Response Correlates with Disease Severity and Outcomes in COVID-19 Patients

por Hashem, Anwar M., Algaissi, Abdullah, Almahboub, Sarah A., Alfaleh, Mohamed A., Abujamel, Turki S., Alamri, Sawsan S., Alluhaybi, Khalid A., Hobani, Haya I., AlHarbi, Rahaf H., Alsulaiman, Reem M., ElAssouli, M-Zaki, Hala, Sharif, Alharbi, Naif K., Alhabbab, Rowa Y., AlSaieedi, Ahdab A., Abdulaal, Wesam H., Bukhari, Abdullah, AL-Somali, Afrah A., Alofi, Fadwa S., Khogeer, Asim A., Pain, Arnab, Alkayyal, Almohanad A., Almontashiri, Naif A. M., Ahmad, Bakur Mahmoud, Li, Xuguang
Publicado 2020